Alevin Therapeutics

Developer of targeted integrin therapies for multiple diseases

placeCambridge, England, United Kingdom calendar_todayFounded 2022 groups4 employees language alevintherapeutics.com

Registered entities

Social engagement

Social engagement: 526 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

9 Sep 2025
Partnership
Alevin Therapeutics
Coming soon